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Abstract
Background: As a rule, endocervical tumours with signet-ring cell are classed as metastatic extra-genital
neoplasms. In a patient aged 45 years, we describe primary cervical signet-ring cell carcinoma (PCSRCC)
characterized by prominent endometrial and myometrial involvement, simulating primary endometrial
adenocarcinoma with cervical extension. In addition, a review was made of the literature to identify the clinical and
pathological features of this rare malignancy.
Case presentation: A 45-year-old woman was referred to our Gynaecology Department due to persistent
abnormal vaginal bleeding. Transvaginal ultrasonography showed slight endometrial irregularities in the whole
uterine cavity suggestive of endometrial neoplasms. Pelvic magnetic resonance imaging revealed diffuse
enlargement of the cervix, which had been replaced by a mass. Induration extended to the parametria and
sigmoid colon fat.
Histological examination of endometrial curettage and a cervical biopsy revealed a neoplasm characterized by
neoplastic signet-ring cells and trabecular structures. Immunohistochemical analysis and molecular studies showed
certain findings consistent with a cervical neoplasm, such as positivity to CEA, keratin 7, Ca-125 and p16 and the
presence of HPV (Human Papilloma Virus) DNA 18.
On examination of the hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy, the
lesion replacing the cervix, endometrium and myometrium, revealed the same immunohistochemical findings
observed on endometrial curettage and cervical biopsy specimens. Metastases were found in an ovarian cystic
lesion and the lymph nodes.
Conclusion: With this report the authors have demonstrated that the spread of cervical adenocarcinoma to the
uterine corpus, although rare, may be observed, and that in this instance immunohistochemical and molecular
studies can provide sufficient information for accurate diagnosis even on small biopsy specimens.
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Signet-ring cell carcinoma is an epithelial malignancy
characterized by the presence of cells with a signet-ring
appearance. This appearance is due to a large vacuole
full of mucin displacing the nucleus to the periphery.
Thus, the pool of mucin in a signet-ring cell mimics the
appearance of a finger hole, while the nucleus represents
the face of the ring in profile [1]. Signet-ring cell carci-
noma is considered a form of adenocarcinoma [1].
Signet-ring cells are most frequently associated with
stomach cancer [1], but may be observed in any tissue
including the prostate [2] bladder, gallbladder [3] breast,
and colon [4] as well as in stromal tumours of the ovary
and testis [5].
Most signet-ring cell carcinomas in the female genital
tract are extra-genital metastatic neoplasms [3,6-9].
Primary signet-ring carcinomas of the female genital
organs, on the other hand, may be considered a rare
event. In fact, primary signet-ring cell carcinoma of the
endometrium has only been observed in 4 previous
cases [10-12].
Moreover, to the best of our knowledge, no more than
14 cases of primary cervical carcinoma containing sig-
net-ring cells have been reported in the English litera-
ture [13-22].
In this paper, we report a new case of primary signet-
ring cell carcinoma of the cervix (PSRCC) with promi-
nent endometrial and myometrial involvement simulat-
ing endometrial adenocarcinoma with extension to the
cervix or metastatic extra-genital tumour (OK). The
results of immunohistochemical and molecular studies
have been reported as ancillary techniques to provide
information for a more accurate diagnosis of this rare
malignancy. In addition, we reviewed the literature to
identify the clinical and pathological features of this rare
malignancy.
Case presentation
The materials consisted of cervical and endometrial
biopsy specimens, plus specimens from hysterectomy
with bilateral salpingo-oophorectomy and pelvic lym-
phadenectomy. The specimens were fixed in 10% neu-
tral-buffered formalin for a routine light microscope
examination. The samples were embedded in paraffin,
then 3μ sections were cut and stained with haematoxy-
lin-eosin. Immunohistochemistry was performed with
antibodies anti-Ca 125 (Dilution 1:100, clone: M11,
Dako, Glostrup, Denmark), CEA (Dilution 1:200, clone:
11-7, Dako, Glostrup, Denmark), anti keratin 7 (Dilu-
tion:1:200, clone OV-TL 12/30, Neomarkers, Pleasalton-
CA), and p16
INK4a (Kit Cinetec p16
INK4a, Heidelberg,
Germany), Vimentin (Neomarkers, dilution:1:500, clone:
V9, Neomarkers, Pleasalton-CA), anti-oestrogen recep-
tors (Dilution:1:50, clone: SP1, Neomarkers, Pleasalton-
CA), anti-progesterone receptors, (Dilution:1:200, clone:
P8R636, Dako, Glostrup, Denmark), Chromogranin A
(Dilution:1:2000, clone: LK 2H10+ PHE5, Neomarkers,
Fremont-CA) and Synaptophysin (Dilution:1:100, poly-
clonal, Cell Marque, Hot Springs, AR, USA), using the
avidin-biotin method.
Polymerase chain reaction amplification (PCR) was
performed to evaluate the presence of HPV DNA in the
cervical and endomyometrial neoplasm.
For DNA extraction, 4 μm-thick histological sections
were stained with haematoxylin and examined under a
stereomicroscope. Neoplastic areas were manually
micro-dissected using sterile scalpels, suspended in a
buffer for tissue lysis (Tris HCl 50 mM, pH 9, 1 mM
EDTA pH 8.0, 0.5% Tween 20, 5% Chelex 100), and
incubated overnight with Proteinase K (0.4 mg/ml) at
55°C. After enzyme inactivation by 10 min boiling, DNA
extracted was used directly in the PCR mix, without
further purification.
HPV-PCR amplification was performed with L1 con-
sensus primers Gp5+/Gp6+ [23], giving an expected
PCR product size of 150 bp: these primers, which were
distinct but pooled, have been developed to allow the
detection of a broad spectrum of mucosotropic HPV
genotypes (6, 11, 13, 16, 18, 30-35, 39, 40, 42, 45, 51-53,
5 6 ,5 8 ,6 1 ,6 6 ) .M o s to ft h e s eg e n o t y p e sa r ec o r r e l a t e d
with lesions of high oncogenic risk (16,18,45,56 and 58).
Five μl of appropriately diluted DNA were combined in
a2 5μl reaction mixture containing 10 mM Tris-HCl
( p H9 . 0 ) ,5 0m MK C l ,0 . 1 %T r i t o nX - 1 0 0 ,2 0 0μMo f
e a c hd N T P( P r o m e g a ,M a d i s o n ,W I ,U S A ) ,0 . 4μMo f
each primer, 2.0 mM MgCl2, 1.25 U Taq polymerase
(Promega, Madison, WI, USA). Amplification was car-
ried out for 40 cycles in an AB 2700 (Applied Biosys-
tems, Foster City, CA, USA) thermal cycler. Each cycle
of amplification consisted of 1 min denaturation at 94°
C, 1 min annealing at 46°C, and 1 min of elongation at
72°C. The first cycle was preceded by 7 min denatura-
tion at 94°C while the last cycle was followed by a 7
min elongation step at 72°C. PCR for human b-globin
gene was performed to establish the presence of amplifi-
able DNA and to exclude the presence of inhibitory fac-
tors of the PCR reaction [24]. Sequencing of the GP5
+/GP6+ amplimer was performed as follows. PCR reac-
tion was slightly modified, using 1 pM of each primer,
1 . 5m MM g C l 2a n d1 . 2 5u n i t so fA m p l i T a qG o l d
(Applied Biosystem, Foster City, CA). Amplification
conditions were as previously indicated. PCR products
were purified using the NucleoSpin
® Extract II kit
(Macherey-Nagel, Düren-Germany) according to manu-
facturer’s instruction. DNA sequencing was performed
by Eurofins MWG Operon/M-Medical (Milano, IT).
Sequencing results were verified in our laboratory in
both sense and anti-sense directions using DNA STAR
Giordano et al. World Journal of Surgical Oncology 2012, 10:7
http://www.wjso.com/content/10/1/7
Page 2 of 9PC software (Lasergene, Madison, WI USA). HPV type
was determined using the BLAST (Basic Local Align-
ment Search Tool) Search function of the Papilloma
Virus Episteme (PaVE) Database (http://pave.niaid.nih.
gov).
The patient was a 45-year-old woman who had been
referred to our Gynaecology Department because of per-
sistent abnormal vaginal bleeding. Gynaecological exam-
ination revealed diffuse enlargement of the cervix which
had been replaced by an exophytic ulcerated, reddish
lesion. Transvaginal ultrasonography showed slight
endometrial irregularities in the whole uterine cavity
suggestive of endometrial neoplasms. Pelvic magnetic
resonance imaging revealed diffuse enlargement of the
cervix which had been replaced by a mass. Induration
extended to the parametria and sigmoid colon fat. (Pre-
operative FIGO stage: IIB).
Endometrial curettage and cervical biopsy were per-
formed. On histological examination, both specimens
revealed the presence of a neoplasm characterized by
neoplastic signet-ring cells and trabecular structures
(Figure 1).
Periodic acid Schiff (PAS) and blue alcian stains
revealed the presence of intracellular mucin in the sig-
net-ring cells.
Immunohistochemical analysis showed findings consis-
tent with a primary cervical neoplasm, including positivity
to keratin 7, Ca-125, CEA, and p16 and negativity to
Vimentin in both endometrial (Figure 2) and cervical
biopsy (Figure 3), oestrogen and progesterone receptors.
The cervical origin of the neoplasm was also supported by
the presence of HPV DNA (Figure 4) by Polymerase chain
reaction amplification (PCR) and sequencing analysis
which demonstrated the presence of HPV 18 (Figure 5).
The cervical origin of the neoplasm was further
demonstrated by the absence of other neoplasms on
oral endoscopy, thorax, abdominopelvic computed
tomography, colonoscopy and mammography study.
The absence of immunoreactivity to Chromogranin
Aa n ds y n a p t o p h y s i ne x c luded neuro-endocrine
differentiation.
A total abdominal hysterectomy, bilateral salpingo-
oophorectomy, and selective pelvic lymphadenectomy,
omentectomy and resection of sigmoid colon were
performed.
Macroscopic examination of the hysterectomy speci-
men revealed an ulcerated cervical mass and irregulari-
ties in the whole endometrial cavity. On cut section,
w h i t en e o p l a s t i ct i s s u ee x t e n d e dt h r o u g ht h ee n t i r e
myometrial wall thickness to involve the uterine serosa.
Examination of bilateral salpingo-oophorectomy speci-
mens revealed a right ovarian cystic lesion with multiple
white nodules on its surface. White neoplastic nodules
were also observed in the sigmoid colon fat.
Microscopic evaluation confirmed the initial diagnosis
of primary cervical adenocarcinoma with signet-ring ele-
ments and prominent endometrial and myometrial
involvement.
Characteristically, the entire endometrial mucosa and
myometrial wall thickness were involved. The endome-
trial component consisted of trabecular and glandular
structures and signet-ring elements which accounted for
30% of the tumour (Figure 6A). In the myometrial part,
the tumour was characterized by lakes of mucus in
which neoplastic elements were floating (Figure 6B). All
the nodules observed in the sigmoid colon fat and the
cystic lesion of the right ovary were metastases of the
cervical neoplasm, while other metastases were observed
in 3 pelvic lymph nodes.
Discussion
It is universally recognized that adenocarcinomas
which accumulate mucin in large single or aggregated
Figure 1 On histological examination both endometrial
curettage (A: Haematoxylin-Eosin × 100) and cervical biopsy
(B: Haematoxylin-Eosin × 200) specimens revealed the
presence of a neoplasm characterized by neoplastic signet-ring
cells and trabecular structures.
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ipherally, correspond to signet-ring cell carcinoma.
In certain tissues these malignancies are generally
characterized by poor prognosis [25,26].
Several researchers have reported artifactual vacuoles
and non-adenocarcinomatous neoplasms in various
organs and tissues, including the prostate, lymphomas
and the ovaries [27-30].
Non-neoplastic endometrial stromal signet-ring cells
may be observed during decidualization, when endome-
trial stromal cells acquire cytoplasmic vacuoles second-
ary to the accumulation of glycogen and glycoproteins
[31,32]. A lack of staining for mucin as well as immuno-
histochemical non-reactivity for epithelial markers typi-
cally allows recognition of these non-neoplastic
elements.
The presence of signet-ring cells in a carcinoma
within the cervix or in other organs of the genital tract
strongly suggests the possibility of a metastasis from a
primary tumour of the breast or gastrointestinal tract
[3,6-9]. Immunohistochemical and molecular studies
have provided information for differential diagnosis in
some instances. Monteagudo et al o b s e r v e dt h a ti nt h e
majority of cases, the signet-ring variant of breast cancer
metastatic to the ovary showed positivity to gross cystic
disease fluid protein -15 (GCDFP-15) [33]. In contrast,
immunoreactivity to colorectal antigens such as CEA,
CDX-2 (20) and CK 20 [19] in a cervical lesion does not
rule out a diagnosis of primary cervical carcinoma.
As well as cervical cases, adenocarcinomas express
markers common to gastric, intestinal and pancreatobili-
ary epithelial cells [34]. Moreover, simultaneous positiv-
ity to CEA and keratin 7 do not differentiate between
PCSRCC and mammary metastatic malignancy [35].
To the best of our knowledge, only 14 cases of pri-
mary cervical carcinoma containing signet-ring cells
have been reported in the English literature [13-22]
(Table 1).
The majority of the patients in these reports are post-
menopausal women [13,14,16,19,22]. Conspicuous
Figure 2 Immunohistochemical analysis of endometrial neoplasm showed findings consistent with a primary cervical neoplasm, i.e.
positivity to Ca-125 (A × 200), CEA (B × 100), and p16 (C × 200) and negativity to Vimentin (D × 200).
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18,19,22], while concomitant glandular structures
[16,20] or tubular and tubuloglandular formations
[13,15] have been described in some cases. In the case
reported by Insabato et al, the neoplasm was associated
with adenocarcinoma in situ ( A I S )[ 1 8 ]a n di nt h a t
described by Haswani et al,b o t hA I Sa n dah i g h - g r a d e
squamous intraepithelial lesion were present [15], but
these were absent in our case. A simultaneous glassy
cell component was observed in a young Japanese
Figure 3 Immunohistochemical analysis of cervical neoplasm showed findings consistent with a primary cervical neoplasm, i.e.
positivity to Ca-125 (A × 100), CEA (B × 200), p16 (C × 200) and negativity to Vimentin (D × 400).
Figure 4 Results of HPV-PCR amplification using the L1 consensus primers Gp5+/Gp6+ showing strong positivity for HPV-DNA in both
endometrial and biopsy specimens: Lanes 1, 2, 3: CL (Cervical neoplastic lesion) DNA at three different dilutions, with strong signal for
HPV-DNA. Lanes 4:, 5, 6: EL (Endometrial neoplastic lesion) DNA at three different dilutions, with strong signal for HPV-DNA. M: molecular weight
standard; + = HPV positive control; - = HPV negative control.
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immunophenotype with consistent expression of CDX2
marker has been described by McCluggage et al [20].
Oestrogen and Progesterone receptors have been
tested in only 4 previous cases [15-17,19,21] and these
were present only in one example [16].
Neuroendocrine differentiation by using neuroendo-
crine markers such as Chromogranin A [19] and both
Chromogranin A and Synatophysin [16] have been
demonstrated in two cases, but these markers were
negative in our case.
In our case, as well as in some previous published
examples of the PCSRCC, the primary cervical origin
was supported by the presence of HPV DNA using
molecular analysis [15,22] and by P16 immunoreactivity
[20,22], which may be considered a surrogate marker for
HPV infection [36].
Prognosis for PCSRCC is not well understood because
of its rarity [13-22]. Moreover, is not possible to draw
convincing conclusions about the prognostic significance
of signet-ring component in endocervical carcinoma
since the follow-up period in the majority of the previous
cases reported in the literature is either too short [15-17]
or was not reported [20,22] (Table 1). However, in our
opinion, prognosis in this rare malignancy should be con-
sidered poor at more advanced stages of the disease.
This hypothesis is supported by data in the literature
which show that all patients with an advanced stage of
development of neoplasm (stage III sec FIGO) died
from the disease after only 10 [13] or 18 months [15,19]
a n d7w e e k sa n d2m o n t h sf r o md i a g n o s i s[ 2 1 ] .M o r e -
over, in these examples of PRSCC, the authors had also
documented that this rare malignancy showed resistance
to radiotherapy and/or chemotherapy [13,15,19,21]. In
cases observed by Veras et al, the PCSRCC were charac-
terized by widespread metastatic disease with systemic
thromboembolic phenomena (Trousseau syndrome) and
both patients expired shortly after initiation of che-
motherapy (Table 1). In these cases, Veras et al
excluded metastatic adenocarcinomas of the upper gas-
trointestinal tract origin because of the presence of HPV
DNA by in situ hybridization [21].
In cases with a lower stage of development (stage Ib
sec FIGO) prognosis is better. Indeed, in the cases
described by Mayorga et al and Insabato et al,t h e
patients showed no evidence of disease several months
after diagnosis [14,18].
Generally, cervical carcinoma spreads to the parame-
tria and/or vagina. In our case, the neoplasm had
involved the uterine corpus and showed prominent
endometrial and myometrial infiltration simulating pri-
mary endometrial adenocarcinoma with cervical exten-
sion. Data from the literature reveal that the spread of
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Figure 5 Sequence alignment illustrating 100% identities
between Human papillomavirus type 18 reference sequence
(PAVE entry X05015.1) and HPV DNA from both endometrial
and cervical specimens. (End: endometrial lesion)
Figure 6 Microscopic examination of hysterectomy specimen
revealed the presence of neoplasm with endometrial and
myometrial involvement. The endometrial component of the
neoplasm was formed by predominant trabecular and glandular
structures (A: Haematoxylin-Eosin × 40) In the myometrial part, the
tumour was characterized by lakes of mucus in which neoplastic
elements floated (B: Haematoxylin-Eosin × 100).
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may be observed [16,37-39].
As in our case, in the series of Yemelyanova et al,t h e
cervical origin of the malignancy was demonstrated
using immunohistochemical and molecular studies
which respectively revealed immunoreactivity to p16
and negativity to hormone receptors plus the presence
of HPV DNA in both the corpus and cervical compo-
nent of the neoplasm [39].
In our case, negativity to Vimentin and positivity to
CEA proved useful in excluding primary signet-ring cell
carcinoma of the endometrium an entity even rarer than
PCSRCC [10-12].
Positivity to p16 protein and molecular analysis using
PCR revealed that this rare entity is related to HPV
infection in the same way as other subtypes of primary
adenocarcinoma [39-42].
Conclusion
With this report the authors have demonstrated that the
spread of cervical adenocarcinoma to the uterine corpus,
although rare, may be observed, and that in this instance
Table 1 Previous Reported cases of PCSRCC
Authors Age
(yrs)
Presenting symptoms Histological features
associated
and
FIGO stage
HPV ER/
PGR
Treatment Outcome
Moll et al
(1990)
50 Post-coital vaginal bleeding,
menometrorrhagia
III (metastases of ovary and
lymph nodes)
Not done Not
done
Surgery and
whole pelvic
irradiation
DOD 10
mo
Mayorga et
al (1997)
68
74
Post-coital bleeding
Post-menopausal bleeding
Ib
Ib
Not done
Not done
Not
done
Not
done
Preoperative
chemotherapy
and surgery
Surgery
NED 35
mo
NED 25
mo
Haswani et
al (1998)
33
38
Asymptomatic AGC-NOS on a
routine vaginal smear)
Post-coital vaginal bleeding
In both cases previous cervical
condylomas
Adenosquamous ca, III, N1
AIS/HSIL
Ib N1
HPV type 18 by PCR
Not done
-/
–/-
Palliative radio
and
chemotherapy
Surgery and
radiotherapy
DOD 10
mo
NED 18
mo
Cardosi et al.
(1999)
53 Perimenopausal bleeding neuroendocrine
differentiation
Ib
Not done +/+ Surgery,
radiotherapy
Chemotherapy
NED 6
mo
Moritani et al
(2004)
29 Persistent abnormal genital
bleeding
glassy cell component
III b N1
-b y
immunohistochemistry
-/- Chemotherapy NED 6
mo
Insabato et
al (2007)
46 Vaginal bleeding
in cervical polypoid lesion
Ib Not done Not
Done
Surgery
radiotherapy
Chemotherapy
NED 3
yrs
Suárez-
Peñaranda
(2007)
80 Vaginal discharge neuroendocrine
differentiation IIIb
Not done Not
Done
Radiotherapy/
Chemotherapy
DOD 18
mo
McCluggage
WG et al
(2008)
NR Two cases NR Foci of signet-ring cell in
the usual type of cervical
adenocarcinoma
Diffuse positivity to P16
Not done Not
Done
NR NR
Versas E et al
(2009)
36
43
Thromboembolic events (Trousseau
Syndrome)Metastases of lung and
lymph nodes
+ HPV by in situ
hybridization
-/-
-/-
Chemotherapy
Chemotherapy
DOD 7
wks
DOD 2
mo
Balci et al
(2010)
53 Post-menopausal bleeding (0% of neoplasms with SRC
II b3x 5 × 2 parametrio N1
HPV type 18 -/- Surgery NR
AGC-NOS: Atypical Glandular Cells not otherwise specified
AIS: adenocarcinoma in situ
DOD: dead of disease
HSIL: High-grade Squamous Intraepithelial Lesion
HPV: human papilloma virus
Mo: months NED: not evidence of disease
NR: not reported
PCR: Polymerase chain reaction amplification
Yrs: years
Wks: weeks
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vide sufficient information for accurate diagnosis even
on small biopsy specimens.
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